semaglutide on medicaid TennCare's obesity medication coverage is a win for Tennesseans • Tennessee Lookout McKee's proposed FY2027 budget drops

And its important to remember that compounded semaglutide is not FDA-approvedso clinical trial data from brand-name medications doesnt directly apply here

This format suits active people who are often on the move, or those who prefer an alternative to capsules and powders while keeping a clear nutritional organisation

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

Mol Biol Cell (2008) 19(7):297383

Weight loss and reduced caloric intake may lower blood pressure acutely, triggering orthostatic dizziness (dizziness upon standing)